Skip to main content

Table 5 Stillbirth rates by ACS administrationa and ACT intervention group and site

From: The global network antenatal corticosteroids trial: impact on stillbirth

  Argentina Guatemala Pakistan Belgaum
  Treatment Control Treatment Control Treatment Control Treatment Control
Characteristic ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS
Deliveries, N 271 1,297 163 1,551 540 5,135 39 3,812 1,871 5,927 125 8,186 1,743 13,228 332 16,407
Stillbirths, N 5 18 3 24 12 94 0 69 117 271 4 347 80 296 4 377
Stillbirths ≥ 20 weeks GA or ≥ 500 g, N (Rate/1000) 5 (18.5) 18 (13.9) 3 (18.4) 24 (15.5) 12 (22.2) 94 (18.3) 0 (0.0) 69 (18.1) 117 (62.5) 271 (45.7) 4 (32.0) 347 (42.4) 80 (45.9) 296 (22.4) 4 (12.0) 377 (23.0)
  Nagpur Kenya Zambia Total
  Treatment Control Treatment Control Treatment Control Treatment Control
Characteristic ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS ACS No ACS
Deliveries, N 612 5,822 84 6,351 178 5,708 30 7,007 519 3,043 15 4,550 5,734 40,160 788 47,864
Stillbirths, N 36 110 5 164 16 123 5 148 27 62 2 85 293 974 23 1,214
Stillbirths ≥ 20 weeks GA or ≥ 500 g, N (Rate/1000) 36 (58.8) 110 (18.9) 5 (59.5) 164 (25.8) 16 (89.9) 123 (21.5) 5 (166.7) 148 (21.1) 27 (52.0) 62 (20.4) 2 (133.3) 85 (18.7) 293 (51.1) 974 (24.3) 23 (29.2) 1,214 (25.4)
  1. aData on administration of ACS from the MNH Registry are available for 1,267/1,304 (97.2 %) of stillbirths in the intervention group and 1,237/1,264 (97.9 %) of stillbirths in the control group